Sitemap

• About us
  • Our Company
  • Our Team
  • Our R&D programs
  • Our Distributors
  • Career Opportunities
• Lentiviral vectors
  • Lentiviral vectors essentials
  • Vectalys know how
    • Custom lentiviral vectors
  • Ready-to-use lentiviral vectors
    • Fluorescent reporters
    • Bioluminescent reporters
    • Gene editing
    • Pre-made lentiviral vectors with specific promoters
  • Custom lentiviral vectors
  • Large scale lentiviral vectors
  • LentiCRISPR libraries
• Non-integrating lentiviral vectors
  • What is LentiFlash ?
  • Custom LentiFlash
    • LentiFlash MS2RLP
  • Ready-to-use LentiFlash
  • Plasmid expression RLP
• Functional tissue engineering
  • Model generation
  • Stable cell lines
    • Custom stable cell lines
  • Cell engineering
    • Gene editing
    • Cell differentiation
    • Immunotherapy
    • LentiFlash carrying CRISPR-Cas9
  • In vivo models
• Who to contact?
• Newsletter
  • mRNA without cytotoxicity
  • A new approach to gene editing without integration
  • Inducible cell lines in hard to transduce cells?
  • Need to drive your gene expression into specific cells or tissues?
  • Be brilliant with your experiment
  • Have you ever dreamt you could transduce 60% of naive and 90% of activated T lymphocytes?
  • Cross the gap between basic research to clinical assays
  • A bright future for your CNS studies
  • Can I express several genes of interest simultaneously
  • CRISPR library
  • AACR 2017: our latest gene editing & immunotherapy data using LentiFlash
  • Need a large scale production of lentiviral tools ?
  • Want to target gene expression in specific cells or tissues ?
  • Looking for an efficient CRISPR delivery system ?
  • Reporter cell line generation
  • Cell state specific promoters
• Transduce 100% of your target cells

• News
  • Press release Flash Therapeutics in English and French
  • ASGCT 2018: Meet us in Chicago!
  • Vectalys receives the Seal of Excellence from the European Commission
  • Bioproduction des immunothérapies en France
  • Upcoming ESGCT 2017 in Berlin
  • Launch of FlashCell
  • ASGCT 2017 in Washington, DC
  • Lentifactory: Horizon 2020 SME Instrument - phase I
  • AACR Annual Meeting 2017
  • Poster CRISPR congress Berlin 2016
  • Upcoming CRISPR congress Europe in Berlin
  • Fundraising : Vectalys raises 0,9M€
  • Vectalys will attend the ASGCT in Washington
  • Launch of our brand new website
  • Vectalys will attend the AACR Annual Meeting 2016
  • Product launch : LentiFlash
• Technical Ressources
  • FAQ
  • Resources
  • Training
  • Lentiviral vectors safety
  • End user licence agreement
• Legal notices